Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic …
H Cao, X Rao, J Jia, T Yan, D Li - Acta diabetologica, 2023 - Springer
Aims The overall effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors in patients
with advanced chronic kidney disease (CKD)(estimated glomerular filtration rate (eGFR), 15 …
with advanced chronic kidney disease (CKD)(estimated glomerular filtration rate (eGFR), 15 …
Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic …
ES Speedtsberg, M Tepel - Frontiers in Endocrinology, 2023 - frontiersin.org
Background and aims Outcome trials using sodium glucose cotransporter type 2 inhibitors
have consistently shown their potential to preserve kidney function in diabetic and …
have consistently shown their potential to preserve kidney function in diabetic and …
Chronic kidney disease awareness and updates on the management of diabetic kidney disease
W Hamza, JO Burton - Practical Diabetes, 2023 - Wiley Online Library
The prevalence of chronic kidney disease (CKD) is rising worldwide and is a major
contributor to morbidity and mortality. It is estimated to affect over 800 million people …
contributor to morbidity and mortality. It is estimated to affect over 800 million people …
The Effectiveness of SGLT2 Inhibitors in CKD Patients
Abstract Sodium-glucose cotransporter-2 inhibitors, often known as SGLT2Is, are a class of
medications used largely for anti-diabetic activity in oral dose form that lowers blood glucose …
medications used largely for anti-diabetic activity in oral dose form that lowers blood glucose …
[PDF][PDF] Farmácia D'Arrábida, Vila Nova de Gaia e Serviços Farmacêuticos da Azienda Ospedaliero-Universitaria Di Ferrara, Itália
JC da Silva - 2023 - repositorio-aberto.up.pt
O estágio curricular apresenta-se como a fase final de todo o percurso realizado durante o
Mestrado Integrado em Ciências Farmacêuticas. O estágio permite-nos, após cinco anos de …
Mestrado Integrado em Ciências Farmacêuticas. O estágio permite-nos, após cinco anos de …
Diabetes mellitus y su manejo en escenarios difíciles
DC Varela, MD Roldán, SC Palacio… - Ciencia y …, 2023 - dialnet.unirioja.es
Metodología: se seleccionaron 51 artículos sobre diabetes y diferentes escenarios clínicos,
publicados en su mayoría entre los años 2015-2021. Resultados: en los pacientes con …
publicados en su mayoría entre los años 2015-2021. Resultados: en los pacientes con …